Immunogenicity of the Conjugate Meningococcal ACWY-TT Vaccine in Children and Adolescents Living with HIV.

Arantxa BerzosaSara GuillénCristina EpalzaLuis EscosaMaria Luisa NavarroLuis M PrietoTalia SainzSantiago Jimenez de OryMarina MontesRaquel AbadJulio A VázquezIrene Serrano GarcíaJosé Tomás Ramos-Amador

Published in: Microorganisms (2023)

CALHIV who received effective TAR and presented a good immuno-virological situation achieved an appropriate vaccine response after two doses of the Men ACWY-TT vaccine, and antibody-mediated protection against serogroups C, W, and Y was maintained in more than 70% of the patients one year after vaccination.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
cancer therapy
drug delivery
patient reported